AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Inside Putin's Russia; Is China peaking?; Knowledge in the digital age
Fareed Zakaria GPS
The Future of Obesity
Some magletide is the active ingredient in two medications flying off pharmacist shelves in the US right now. The first ozempic came on to the scene in 2017 as a diabetes treatment But the patients in clinical trials reported losing significant weight and rather than include the reaction as a side effect It's maker Novo Nordisk turned it into a lucrative selling point And you may lose weight By 2021 the Danish drug maker started selling wagovii a weight loss specific dose of some agletide aimed at treating obese and overweight adults Early results seem remarkable Company sponsored studies have indicated that those onwagovii can expect to lose around 15% of their body weight after nearly a year and a
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode